Confirming previous results, Rev-erbα-deficient mice were found to display increased activation of the NLRP3 pathway which accounted for the severe phenotype, whereas pharmacological Rev-erb activation attenuated colitis in vivo (Figure 4). Here, NLRP3 is linked to colitis.